HealthcareServices

Global Minimally Invasive Thoracic Surgery Industry Trends: Where the Market Is Headed by 2029

November 20, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Minimally Invasive Thoracic Surgery Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The minimally invasive thoracic surgery market has experienced robust expansion recently. Projections indicate an increase from $4.04 billion in 2024 to $4.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.4%. This historical expansion is largely due to factors such as the increasing prevalence of lung cancer and other thoracic disorders, the rising adoption of robotic-assisted thoracic procedures, a growing geriatric population, enhanced patient awareness, and increasing healthcare expenditure.

The minimally invasive thoracic surgery market is projected for significant expansion over the coming years. This market is set to reach $5.98 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 8.1%. This anticipated growth during the forecast period stems from factors such as an escalating demand for shorter hospital stays, the expanded incorporation of advanced imaging and navigation technologies, surgeons’ increasing preference, augmented government and private funding, and a heightened emphasis on value-based healthcare models. Key trends expected within this period encompass progress in robotic-assisted surgical platforms, enhancements in minimally invasive instrumentation design, the incorporation of artificial intelligence, the integration of augmented and virtual reality tools, and technological breakthroughs in 3D and 4K imaging systems.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27348&type=smp

Which Industry Drivers Are Expected To Accelerate The Minimally Invasive Thoracic Surgery Market From 2025 To 2029?

The increasing occurrence of lung ailments is anticipated to fuel the expansion of the minimally invasive thoracic surgery market in the future. These conditions encompass medical issues that hinder pulmonary function and respiration, including asthma, COPD, pneumonia, and lung cancer. The prevalence of lung disease is primarily escalating due to tobacco smoking, as the detrimental chemicals present in tobacco progressively harm lung cell DNA, thereby raising the probability of unchecked cell proliferation and tumor development. Minimally invasive procedures benefit individuals with lung diseases by targeting and excising or obliterating tumors via small cuts or imaging-guided instruments, leading to quicker recovery, less harm to healthy lung tissue, a diminished chance of complications, and an earlier return to regular activities for patients. As an illustration, in June 2025, data from the Centers for Disease Control and Prevention, a US government body, indicated that in 2022, the United States registered 218,893 new cases of lung cancer, and in 2023, this disease caused 131,584 deaths within the nation. Consequently, the growing frequency of lung conditions is propelling the expansion of the minimally invasive thoracic surgery market.

What Are The Key Segments In The Minimally Invasive Thoracic Surgery Market?

The minimally invasive thoracic surgery market covered in this report is segmented

1) By Type: Lobectomy, Wedge Resection, Pneumonectomy, Other Types

2) By Product: Energy Devices, Instruments, Staplers And Disposables, Visualization Systems

3) By Procedure Type: Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Thoracic Surgery, Endoscopic Thoracic Surgery, Other Procedure Types

4) By Application: Lung Cancer Surgery, Esophageal Surgery, Mediastinal Surgery, Other Applications

5) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Lobectomy: Bilobectomy, Sleeve Lobectomy, Thoracoscopic Lobectomy (VATS Lobectomy), Robotic-Assisted Lobectomy

2) By Wedge Resection: Video-Assisted Thoracoscopic Surgery (VATS) Wedge Resection, Robotic-Assisted Wedge Resection, Open Wedge Resection

3) By Pneumonectomy: Standard Pneumonectomy, Extended Pneumonectomy, Sleeve Pneumonectomy, Thoracoscopic

4) By Other Types: Segmentectomy, Sleeve Resection, Decortication, Bullectomy, Thoracoscopic Resection For Metastasectomy

What Trends Are Expected To Drive The Minimally Invasive Thoracic Surgery Market?

Leading companies within the minimally invasive thoracic surgery market are concentrating on developing innovative technology, such as the robotic-assisted surgery platform, to enhance surgical precision and improve overall clinical results. A robotic-assisted surgery platform is a surgical system that allows surgeons to control robotic arms for performing minimally invasive procedures with significant accuracy, thereby boosting precision, dexterity, and visualization compared to traditional surgery. For example, in June 2024, Monmouth Medical Centre (MMC), a US-based medical institution, introduced the Ion Robotic platform, the Aliya PEF system, and intraoperative AI-driven CT imaging. It provides benefits like increased surgical accuracy, improved patient outcomes, and real-time imaging to aid better decision-making. These technologies collectively enable accurate, minimally invasive lung cancer diagnosis and treatment, resulting in faster recovery and superior outcomes. They offer real-time navigation, non-thermal tumor ablation, and reduced radiation exposure, supporting early detection and effective care.

Who Are The Prominent Global Companies Shaping The Minimally Invasive Thoracic Surgery Market?

Major companies operating in the minimally invasive thoracic surgery market are Johnson And Johnson Services Inc., Medtronic Plc, Koninklijke Philips N.V., Stryker Corporation, GE Healthcare Inc., Olympus Corporation, Intuitive Surgical Operations Inc., Smith & Nephew plc, Teleflex Incorporated, Karl Storz SE & Co. KG, Cook Group Incorporated, CONMED Corporation, NuVasive Inc., Applied Medical Resources Corporation, KLS Martin Group, Aesculap Inc., Medela Inc., Richard Wolf GmbH, B. Braun Melsungen AG, Ackermann Instrumente GmbH, Cmr Surgical, Genesee Biomedical Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/minimally-invasive-thoracic-surgery-global-market-report

Which Geographies Are Emerging As Strong Markets For The Minimally Invasive Thoracic Surgery Industry?

North America was the largest region in the minimally invasive thoracic surgery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive thoracic surgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Minimally Invasive Thoracic Surgery Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27348&type=smp

Browse Through More Reports Similar to the Global Minimally Invasive Thoracic Surgery Market 2025, By The Business Research Company

Polyfluoroalkyl Substances Pfas Waste Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/polyfluoroalkyl-substances-pfas-waste-management-global-market-report

Hydrofluoric Acid Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hydrofluoric-acid-global-market-report

Electronic Grade Hydrofluoric Acid Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/electronic-grade-hydrofluoric-acid-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795